Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.

Román, Juan

Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis. [electronic resource] - Inflammatory bowel diseases Feb 2013 - 221-9 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1536-4844

10.1002/ibd.23020 doi


Adult
Aminosalicylic Acids--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antigens, Differentiation--genetics
Azo Compounds--therapeutic use
CD18 Antigens--genetics
Case-Control Studies
Cohort Studies
Colitis, Ulcerative--drug therapy
Double-Blind Method
Female
Gene Expression Profiling
Genetic Markers
Humans
Interleukin-2 Receptor alpha Subunit--genetics
Logistic Models
Male
Mesalamine--therapeutic use
Middle Aged
Polymerase Chain Reaction
Receptors, Interleukin-1 Type II--genetics
Sensitivity and Specificity
Severity of Illness Index
Transcriptome
Treatment Outcome